Both in Pharmaceuticals
Abbott Laboratories vs Merck & Co.
Over the past year ABT returned −14.1% and MRK returned +73.9%; their daily moves had a correlation of 0.32.
ABT −14.1% MRK +73.9%Growth of $1, one year, split-adjusted
| Metric | ABT | MRK |
|---|---|---|
| Price | $106.20 | $149.52 |
| Market cap | $183.77B | $368.89B |
| Today | +1.56% | +2.18% |
| 1 month | +9.8% | +4.0% |
| 6 months | +18.7% | +33.3% |
| Year to date | −15.2% | +42.0% |
| 1 year | −14.7% | +72.7% |
| Revenue growth (YoY) | +13.0% | +5.1% |
| Gross margin | 57.7% | 73.5% |
| Net margin | 7.4% | −8.0% |
| P/E (TTM) | 33.9× | 116.3× |
| Price / sales | 3.9× | 5.5× |
| Net cash | -$27.00B | -$46.77B |
| Dividend yield | 2.37% | 2.27% |
| Volatility (60d) | 21.3% | 36.0% |
| Short % of float | 1.0% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).